Momentum is building good overall safety results from phase 2 lower back trial and improved results from increased dosages for RA all on track.Market starting to realize that this is not just a single disease treatment Biotech company!
Momentum is building good overall safety results from phase 2...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $3.864M | 3.620M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 74056 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 99486 | 10 |
View Market Depth
| Last trade - 12.33pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |